Prostate cancer drug reduces testosterone levels in as little as 3 days

More than 95 per cent of men who took degarelix for prostate cancer saw their testosterone levels fall dramatically as early as three days after they started treatment, according to a paper in the December issue of BJU International.

If you want to include this story in your blog, copy and paste this formatted text:

<p><a href="http://www.physorg.com/news147529873.html">Prostate cancer drug reduces testosterone levels in as little as 3 days</a></p> <p>More than 95 per cent of men who took degarelix for prostate cancer saw their testosterone levels fall dramatically as early as three days after they started treatment, according to a paper in the December issue of <I>BJU International</I>.</p>